Source: Oncotarget From: news-medical.net A new editorial paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?” A vast majority of breast cancers (~70%) are estrogen receptor-alpha positive (ER+), for which endocrine therapy is the common treatment. However, recurrence often occurs leading to tumor progression, metastasis and …
-
-
Your Wardrobe After Breast Cancer Treatments
-
What’s On the Outside Doesn’t Really Matter Even After Breast Cancer
-
You Had Breast Cancer And I Am So Mad At You
-
There’s Nothing Like Doing What You Most Love in Your Life
-
What To Expect After Your Breast Cancer Treatment Is Completed
